Alps Advisors Inc Voyager Therapeutics, Inc. Transaction History

Alps Advisors Inc

$14.5 Billion
Q2 2024

A detailed history of Alps Advisors Inc transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, Alps Advisors Inc holds 38,149 shares of VYGR stock, worth $223,171. This represents 0.0% of its overall portfolio holdings.

Number of Shares

38,149

Previous 38,353 0.53%

Holding current value

$223,171

Previous $357,000 15.69%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$7.42 - $10.54 $1,513 - $2,150	-204 Reduced 0.53%	38,149 $301,000
Q1 2024 May 14, 2024	BUY	$7.15 - $10.84 $20,856 - $31,620	2,917 Added 8.23%	38,353 $357,000
Q4 2023 Feb 14, 2024	SELL	$6.28 - $8.81 $15,473 - $21,707	-2,464 Reduced 6.5%	35,436 $299,000
Q3 2023 Nov 14, 2023	BUY	$7.55 - $11.25 $286,145 - $426,375	37,900 New	37,900 $293,000
Q2 2021 Aug 11, 2021	SELL	$3.94 - $5.44 $267,061 - $368,734	-67,782 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$4.61 - $9.04 $3,508 - $6,879	761 Added 1.14%	67,782 $319,000
Q4 2020 Feb 03, 2021	BUY	$7.15 - $12.28 $137,930 - $236,893	19,291 Added 40.42%	67,021 $479,000
Q3 2020 Nov 04, 2020	SELL	$10.01 - $13.75 $29,689 - $40,782	-2,966 Reduced 5.85%	47,730 $509,000
Q2 2020 Aug 05, 2020	SELL	$8.05 - $14.21 $134,443 - $237,321	-16,701 Reduced 24.78%	50,696 $640,000
Q1 2020 May 06, 2020	SELL	$6.8 - $14.66 $53,468 - $115,271	-7,863 Reduced 10.45%	67,397 $617,000
Q4 2019 Feb 07, 2020	BUY	$12.82 - $16.85 $20,204 - $26,555	1,576 Added 2.14%	75,260 $1.05 Million
Q3 2019 Nov 04, 2019	SELL	$16.31 - $28.29 $55,584 - $96,412	-3,408 Reduced 4.42%	73,684 $1.27 Million
Q2 2019 Aug 07, 2019	SELL	$19.18 - $27.88 $29,633 - $43,074	-1,545 Reduced 1.96%	77,092 $2.1 Million
Q1 2019 May 01, 2019	BUY	$8.0 - $19.66 $27,152 - $66,726	3,394 Added 4.51%	78,637 $1.51 Million
Q4 2018 Feb 04, 2019	BUY	$8.59 - $18.05 $153,279 - $322,084	17,844 Added 31.09%	75,243 $707,000
Q3 2018 Oct 25, 2018	BUY	$17.11 - $21.74 $179,637 - $228,248	10,499 Added 22.39%	57,399 $1.09 Million
Q2 2018 Aug 02, 2018	BUY	$16.76 - $23.92 $786,044 - $1.12 Million	46,900 New	46,900 $916,000

Others Institutions Holding VYGR

# of Institutions

128

Shares Held

36.7M

Call Options Held

48K

Put Options Held

36.2K

View Full List

About Voyager Therapeutics, Inc.

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $226M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

More about VYGR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Account

Alps Advisors Inc Voyager Therapeutics, Inc. Transaction History